Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023

試験片有効性テストの世界市場予測(~2023年)

◆タイトル:Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
◆商品コード:BT6295
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年5月17日
◆ページ数:123
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、世界主要地域・国
◆産業分野:Biotechnology
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、試験片有効性テストの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品(試薬、コントロール、アッセイキット、消耗品)別分析、種類(実験室、POC検査)別分析、エンドユーザー別分析、地域別分析、試験片有効性テストの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Global specimen validity testing market is projected to grow at 6.3% during the forecast period”
The specimen validity testing market is expected to reach USD 1.49 billion by 2023 from USD 1.10 billion in 2018, at a CAGR of 6.3%. Growth in the drug screening market and the increase in workplace drug testing are fueling the growth of the specimen validity testing market. On the other hand, market growth may be limited to a certain extent due to the emergence of alternative drug screening tests (such as oral fluid drug screening test.)

“Specimen validity testing services are expected to grow at the highest CAGR during the forecast period”
The specimen validity testing market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period; growth in this segment is attributed to the growing implementation of workplace drug testing in several countries, increasing number of drug screening tests, and the growing number of drug screening laboratories across the globe.

“By type, laboratory testing is expected to dominate the market during the forecast period”
The specimen validity testing market is segmented into laboratory testing and rapid/POC testing. The laboratory testing segment is expected to dominate the market during the forecast period. The accuracy of test results and cost-effectiveness of laboratory testing are other key factors driving the demand for this segment.
“Asia Pacific to witness high growth during the forecast period”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period. The high growth in the APAC regional segment is attributed to the developing healthcare infrastructure, rising adoption of stringent regulatory guidelines for drug testing, increase in the number of illicit drug users, and strategic expansion of key market players in the region.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 24%; Tier 2 – 32%; Tier 3 – 44%.
• By Designation: C-level- 26%; D-level- 30%; others–44%.
• By Region: North America-48%; Europe-37%; Asia Pacific-10%; RoW-5%.
List of companies profiled in the report
• Alere (Subsidiary of Abbott Laboratories) (US)
• Thermo Fisher (US)
• Scitek (US)
• LabCorp (US)
• Quest Diagnostics (US)
• Alfa Scientific Designs (US)
• American Bio Medica Corporation (US)
• Express Diagnostics (US)
• ACM Global Laboratories (US)
• Clinical Reference Laboratory (CRL)
• Premier Biotech (US)

Research Coverage:
The report provides an overview of the specimen validity testing market. It aims at estimating the market size and growth potential of this market across different segments such as product and service, type, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in the specimen validity testing market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 15
1.5 LIMITATION 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH DATA 16
2.2 SECONDARY DATA 17
2.2.1 SECONDARY SOURCES 17
2.3 PRIMARY DATA 18
2.3.1 PRIMARY SOURCES 18
2.3.2 KEY INDUSTRY INSIGHTS 19
2.4 MARKET ESTIMATION 20
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.6 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 28
4.1 SPECIMEN VALIDITY TESTING MARKET OVERVIEW 28
4.2 SPECIMEN VALIDITY TESTING MARKET, BY TYPE (2018 VS. 2023) 28
4.3 SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE (2018 VS. 2023) 29
4.4 GEOGRAPHIC ANALYSIS: EUROPEAN SPECIMEN VALIDITY TESTING MARKET,
BY END USER AND REGION (2018) 30
4.5 GEOGRAPHIC SNAPSHOT: SPECIMEN VALIDITY TESTING MARKET (2018–2023) 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Growth in the drug screening market 33
5.2.1.2 Increase in workplace drug testing 33
5.2.2 RESTRAINTS 34
5.2.2.1 Emergence of alternative drug screening tests 34
5.2.3 MARKET OPPORTUNITIES 34
5.2.3.1 Rapid/Point-of-care specimen validity testing 34
5.2.4 MARKET TRENDS 35
5.2.4.1 Market consolidation 35
5.2.4.2 Regulatory approvals for rapid testing products 35
6 SPECIMEN VALIDITY TESTING MARKET, BY PRODUCT & SERVICE 36
6.1 INTRODUCTION 37
6.2 PRODUCTS 38
6.2.1 REAGENTS, CALIBRATORS, AND CONTROLS 39
6.2.2 ASSAY KITS 40
6.2.3 DISPOSABLES 41
6.3 SERVICES 43
7 SPECIMEN VALIDITY TESTING MARKET, BY TYPE 45
7.1 INTRODUCTION 46
7.2 LABORATORY TESTING 47
7.3 RAPID/POC TESTING 49
8 SPECIMEN VALIDITY TESTING MARKET, BY END USER 51
8.1 INTRODUCTION 52
8.2 WORKPLACES 53
8.3 DRUG SCREENING LABORATORIES 54
8.4 CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES 56
8.5 PAIN MANAGEMENT CENTERS 58
8.6 DRUG REHABILITATION CENTERS 59
8.7 OTHER END USERS 61
9 SPECIMEN VALIDITY TESTING MARKET, BY REGION 63
9.1 INTRODUCTION 64
9.2 NORTH AMERICA 66
9.2.1 US 68
9.2.2 CANADA 70
9.3 EUROPE 73
9.3.1 GERMANY 76
9.3.2 FRANCE 77
9.3.3 UK 79
9.3.4 REST OF EUROPE (ROE) 81
9.4 ASIA PACIFIC 84
9.5 REST OF THE WORLD (ROW) 88

10 COMPETITIVE LANDSCAPE 92
10.1 INTRODUCTION 92
10.2 MARKET RANKING ANALYSIS, BY KEY PLAYER 93
10.3 COMPETITIVE SCENARIO 94
10.3.1 PRODUCT LAUNCHES AND APPROVALS 94
10.3.2 ACQUISITIONS 95
10.3.3 PARTNERSHIP, AGREEMENTS, AND COLLABORATION 95
10.3.4 EXPANSIONS 95
11 COMPANY PROFILES 96
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 ALERE (SUBSIDIARY OF ABBOTT LABORATORIES) 96
11.2 THERMO FISHER SCIENTIFIC 98
11.3 LABCORP 100
11.4 QUEST DIAGNOSTICS 102
11.5 AMERICAN BIO MEDICA CORPORATION (ABMC) 104
11.6 SCITECK 106
11.7 PREMIER BIOTECH 107
11.8 ALFA SCIENTIFIC DESIGNS 108
11.9 ACM GLOBAL LABORATORIES 110
11.10 EXPRESS DIAGNOSTIC INTERNATIONAL 111
11.11 CLINICAL REFERENCE LABORATORY 112

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 113
12.1 INSIGHTS FROM INDUSTRY EXPERTS 113
12.2 DISCUSSION GUIDE 114
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 117
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 119
12.5 AVAILABLE CUSTOMIZATIONS 120
12.6 RELATED REPORTS 120
12.7 AUTHOR DETAILS 121

LIST OF TABLES

TABLE 1 RECENT PRODUCT LAUNCHES (2015–2017) 34
TABLE 2 RECENT ACQUISITIONS (2017) 35
TABLE 3 RECENT FDA APPROVALS FOR RAPID TESTING PRODUCTS (2017–2018) 35
TABLE 4 SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 37
TABLE 5 SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 38
TABLE 6 SPECIMEN VALIDITY TESTING MARKET FOR REAGENTS, CALIBRATORS,
AND CONTROLS, BY REGION, 2016–2023 (USD MILLION) 39
TABLE 7 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR REAGENTS, CALIBRATORS, AND CONTROLS, BY COUNTRY, 2016–2023 (USD MILLION) 39
TABLE 8 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR REAGENTS, CALIBRATORS, AND CONTROLS, BY COUNTRY, 2016–2023 (USD MILLION) 40
TABLE 9 SPECIMEN VALIDITY TESTING MARKET FOR ASSAY KITS, BY REGION,
2016–2023 (USD MILLION) 40
TABLE 10 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR ASSAY KITS,
BY COUNTRY, 2016–2023 (USD MILLION) 41
TABLE 11 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR ASSAY KITS, BY COUNTRY, 2016–2023 (USD MILLION) 41
TABLE 12 SPECIMEN VALIDITY TESTING MARKET FOR DISPOSABLES, BY REGION,
2016–2023 (USD MILLION) 42
TABLE 13 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR DISPOSABLES,
BY COUNTRY, 2016–2023 (USD MILLION) 42
TABLE 14 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR DISPOSABLES,
BY COUNTRY, 2016–2023 (USD MILLION) 42
TABLE 15 SPECIMEN VALIDITY TESTING SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 43
TABLE 16 NORTH AMERICA: SPECIMEN VALIDITY TESTING SERVICES MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 43
TABLE 17 EUROPE: SPECIMEN VALIDITY TESTING SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 44
TABLE 18 SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016-2023 (USD MILLION) 46
TABLE 19 LABORATORY TESTING MARKET, BY REGION, 2016-2023 (USD MILLION) 47
TABLE 20 NORTH AMERICA: LABORATORY TESTING MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 48
TABLE 21 EUROPE: LABORATORY TESTING MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 48
TABLE 22 RAPID/POC TESTING MARKET, BY REGION, 2016-2023 (USD MILLION) 49
TABLE 23 NORTH AMERICA: RAPID/POC TESTING MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 50
TABLE 24 EUROPE: RAPID/POC TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 50
TABLE 25 SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION) 52
TABLE 26 SPECIMEN VALIDITY TESTING MARKET FOR WORKPLACES, BY REGION,
2016–2023 (USD MILLION) 53
TABLE 27 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR WORKPLACES,
BY COUNTRY, 2016–2023 (USD MILLION) 53
TABLE 28 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR WORKPLACES,
BY COUNTRY, 2016–2023 (USD MILLION) 54
TABLE 29 SPECIMEN VALIDITY TESTING MARKET FOR DRUG SCREENING LABORATORIES,
BY REGION, 2016–2023 (USD MILLION) 54
TABLE 30 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR DRUG SCREENING LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION) 55
TABLE 31 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR DRUG SCREENING LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION) 55
TABLE 32 SPECIMEN VALIDITY TESTING MARKET FOR CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY REGION, 2016–2023 (USD MILLION) 56
TABLE 33 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2016–2023 (USD MILLION) 57
TABLE 34 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2016–2023 (USD MILLION) 57
TABLE 35 SPECIMEN VALIDITY TESTING MARKET FOR PAIN MANAGEMENT CENTERS,
BY REGION, 2016–2023 (USD MILLION) 58
TABLE 36 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 58
TABLE 37 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 59
TABLE 38 SPECIMEN VALIDITY TESTING MARKET FOR DRUG REHABILITATION CENTERS,
BY REGION, 2016–2023 (USD MILLION) 60
TABLE 39 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR DRUG REHABILITATION CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 60
TABLE 40 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR DRUG REHABILITATION CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 60
TABLE 41 SPECIMEN VALIDITY TESTING MARKET FOR OTHER END USERS,
BY REGION, 2016–2023 (USD MILLION) 61
TABLE 42 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION) 61
TABLE 43 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2016–2023 (USD MILLION) 62
TABLE 44 SPECIMEN VALIDITY TESTING MARKET, BY REGION, 2016–2023 (USD MILLION) 65
TABLE 45 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 67
TABLE 46 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 67
TABLE 47 NORTH AMERICA: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 67
TABLE 48 NORTH AMERICA: SPECIMEN VALIDITY TESTING PRODUCTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 68
TABLE 49 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 68
TABLE 50 US: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 69
TABLE 51 US: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 69
TABLE 52 US: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 70
TABLE 53 US: SPECIMEN VALIDITY TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 70
TABLE 54 CANADA: SPECIMEN VALIDITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 71
TABLE 55 CANADA: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 71
TABLE 56 CANADA: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 72
TABLE 57 CANADA: SPECIMEN VALIDITY TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 72
TABLE 58 EUROPE: SPECIMEN VALIDITY TESTING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 74
TABLE 59 EUROPE: SPECIMEN VALIDITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 74
TABLE 60 EUROPE: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 74
TABLE 61 EUROPE: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 75
TABLE 62 EUROPE: SPECIMEN VALIDITY TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 75
TABLE 63 GERMANY: SPECIMEN VALIDITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 76
TABLE 64 GERMANY: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 76
TABLE 65 GERMANY: SPECIMEN VALIDITY TESTING PRODUCTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 77
TABLE 66 GERMANY: SPECIMEN VALIDITY TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 77
TABLE 67 FRANCE: SPECIMEN VALIDITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 78
TABLE 68 FRANCE: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 78
TABLE 69 FRANCE: SPECIMEN VALIDITY TESTING PRODUCTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 78
TABLE 70 FRANCE: SPECIMEN VALIDITY TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 79
TABLE 71 UK: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 80
TABLE 72 UK: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 80
TABLE 73 UK: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 80
TABLE 74 UK: SPECIMEN VALIDITY TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 81
TABLE 75 ROE: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 82
TABLE 76 ROE: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 82
TABLE 77 ROE: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 82
TABLE 78 ROE: SPECIMEN VALIDITY TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 83
TABLE 79 ASIA PACIFIC: SPECIMEN VALIDITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 86
TABLE 80 ASIA PACIFIC: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 86
TABLE 81 ASIA PACIFIC: SPECIMEN VALIDITY TESTING PRODUCTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 86
TABLE 82 ASIA PACIFIC: SPECIMEN VALIDITY TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 87
TABLE 83 ROW: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 90
TABLE 84 ROW: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 90
TABLE 85 ROW: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 90
TABLE 86 ROW: SPECIMEN VALIDITY TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 91
TABLE 87 SPECIMEN VALIDITY TESTING MARKET RANKING (2017), BY KEY PLAYER 93
TABLE 88 PRODUCT LAUNCHES AND APPROVALS 94
TABLE 89 MERGERS AND ACQUISITIONS 95




LIST OF FIGURES

FIGURE 1 SPECIMEN VALIDITY TESTING MARKET 14
FIGURE 2 RESEARCH DESIGN 16
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION 19
FIGURE 4 BOTTOM-UP APPROACH 20
FIGURE 5 TOP-DOWN APPROACH 21
FIGURE 6 DATA TRIANGULATION METHODOLOGY 22
FIGURE 7 SPECIMEN VALIDITY TESTING MARKET SNAPSHOT: LABORATORY TESTING VS RAPID/POC TESTING (2018 VS. 2023) 24
FIGURE 8 SPECIMEN VALIDITY TESTING SERVICES TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 25
FIGURE 9 REAGENTS, CALIBRATORS, & CONTROLS TO DOMINATE THE SPECIMEN VALIDITY TESTING PRODUCTS MARKET IN 2018 25
FIGURE 10 WORKPLACES SEGMENT TO DOMINATE THE SPECIMEN VALIDITY TESTING MARKET IN 2018 26
FIGURE 11 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 27
FIGURE 12 INCREASE IN WORKPLACE DRUG TESTING IS DRIVING THE GROWTH OF THE SPECIMEN VALIDITY TESTING MARKET 28
FIGURE 13 LABORATORY TESTING SEGMENT WILL CONTINUE TO DOMINATE THE MARKET
IN 2023 28
FIGURE 14 REAGENTS, CALIBRATORS, AND CONTROLS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD (2018–2023) 29
FIGURE 15 WORKPLACES SEGMENT TO DOMINATE THE EUROPEAN SPECIMEN VALIDITY TESTING MARKET IN 2018 30
FIGURE 16 SPECIMEN VALIDITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS 32
FIGURE 17 SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION) 37
FIGURE 18 REAGENTS, CALIBRATORS, AND CONTROLS TO DOMINATE THE SPECIMEN VALIDITY TESTING PRODUCTS MARKET IN 2018 38
FIGURE 19 RAPID/POC TESTING SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 46
FIGURE 20 WORKPLACE DRUG TESTING TO DOMINATE THE SPECIMEN VALIDITY TESTING MARKET DURING THE FORECAST PERIOD 52
FIGURE 21 NORTH AMERICA TO DOMINATE THE SPECIMEN VALIDITY TESTING MARKET DURING THE FORECAST PERIOD 64
FIGURE 22 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT 66
FIGURE 23 EUROPE: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT 73
FIGURE 24 ASIA PACIFIC: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT 85
FIGURE 25 REST OF THE WORLD: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT 89
FIGURE 26 KEY DEVELOPMENTS IN THE SPECIMEN VALIDITY MARKET BETWEEN
2015 AND 2018 92
FIGURE 27 MARKET EVOLUTION FRAMEWORK 94
FIGURE 28 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017) 96

FIGURE 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 98
FIGURE 30 LABCORP: COMPANY SNAPSHOT (2017) 100
FIGURE 31 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2017) 102
FIGURE 32 AMERICAN BIO MEDICA CORPORATION (ABMC): COMPANY SNAPSHOT (2017) 104




【レポートのキーワード】

試験片有効性検査

★調査レポート[試験片有効性テストの世界市場予測(~2023年)] ( Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023 / BT6295) 販売に関する免責事項
[試験片有効性テストの世界市場予測(~2023年)] ( Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023 / BT6295) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆